Latest Articles
'I felt so weak': NC woman urges awareness after endometrial cancer diagnosis at 32 - WRAL.com
'I felt so weak': NC woman urges awareness after endometrial cancer diagnosis at 32 WRAL.com
Published: July 14, 2025, 5:53 p.m.
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy - Labroots
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy Labroots
Published: July 14, 2025, 10 a.m.
Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano - Oncodaily
Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano Oncodaily
Published: July 12, 2025, 8 p.m.
Divergent Immune-Metabolic Profiles in Endometriosis and Ovarian Cancer: A Cross-Sectional Analysis.
Endometriosis and high-grade serous ovarian cancer (HGS-OC) share common features within the peritoneal immune microenvironment, yet they exhibit divergent clinical outcomes. This study aimed to dissect the immune-metabolic landscape of …
Published: July 12, 2025, midnight
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer - OncLive
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer OncLive
Published: July 11, 2025, 6:17 p.m.
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer TipRanks
Published: July 11, 2025, 4:24 p.m.
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer - MSN
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer MSN
Published: July 9, 2025, 11:31 p.m.
'Overall, I'm in great form' Jennifer Wrynne feeling positive after cancer surgery - EVOKE
'Overall, I'm in great form' Jennifer Wrynne feeling positive after cancer surgery EVOKE
Published: July 9, 2025, 6:54 p.m.
Study finds cervical cancer risk high in women aged over 65 years - Contemporary OB/GYN
Study finds cervical cancer risk high in women aged over 65 years Contemporary OB/GYN
Published: July 9, 2025, 5:46 p.m.
BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: July 9, 2025, 4:04 p.m.
Link copied to clipboard!